Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tuberculosis vaccine H56IC - AJ Vaccines

Drug Profile

Tuberculosis vaccine H56IC - AJ Vaccines

Alternative Names: Adjuvanted TB subunit vaccine H56IC - AJ Vaccines; AERAS-456; Ag85B-ESAT-6-Rv2660-IC31; H56; H56/IC31 vaccine; H56:IC31; H56IC; TB-vaccine-H56IC – AJ Vaccines; Tuberculosis vaccine H56IC - Statens Serum Institut

Latest Information Update: 19 Feb 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Statens Serum Institut
  • Developer Aeras; AJ Vaccines
  • Class Adjuvants; Recombinant fusion proteins; Subunit vaccines; Synthetic vaccines; Tuberculosis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Tuberculosis

Most Recent Events

  • 31 Jan 2019 Aeras initiates a phase II trial for Tuberculosis in South Africa (NCT03512249)
  • 30 Apr 2018 Aeras plans a phase II trial for Tuberculosis in South Africa and Tanzania , (NCT03512249)
  • 17 Apr 2018 Aeras withdraws a phase II trial for Tuberculosis (Prevention, In volunteers, In children, In adolescents) in South Africa and Tanzania prior to enrolment due to change in sponsorship (PACTR201704002006214)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top